Document is current
Any future updates will be listed below
-
Authors
Keller, Matthew D.
Torres, Victor J. https://orcid.org/0000-0002-7126-0489
Cadwell, Ken https://orcid.org/0000-0002-5860-0661
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI121244, AI121244)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL123340)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 12 October 2019
Revised: 4 December 2019
Accepted: 6 December 2019
First Online: 2 January 2020
Compliance with ethical standards
:
: VJT is an inventor on patents and patent applications filed by New York University, which are currently under commercial license to Janssen Biotech Inc. KC has consulted for or received an honorarium from Puretech Health, Genentech, and AbbVie, Inc., has received research support from Puretech Health and Pfizer, Inc, and has a provisional patent, US Patent Appln. No. 15/625,934.
